Next Article in Journal
Mini Review of Controlled Cortical Impact: A Well-Suited Device for Concussion Research
Previous Article in Journal
Bilinguals’ Working Memory (WM) Advantage and Their Dual Language Practices
Previous Article in Special Issue
Postnatal Migration of Cerebellar Interneurons
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Morphological and Molecular Basis of Cytoplasmic Dilation and Swelling in Cortical Migrating Neurons

by
Yoshiaki V. Nishimura
1,
Yo-ichi Nabeshima
2 and
Takeshi Kawauchi
2,3,*
1
Division of Neuroscience, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aobaku, Sendai, Miyagi 981-8558, Japan
2
Laboratory of Molecular Life Science, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation, 2-2 Minatojima-Minamimachi Chuo-ku, Kobe 650-0047, Japan
3
Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
*
Author to whom correspondence should be addressed.
Brain Sci. 2017, 7(7), 87; https://doi.org/10.3390/brainsci7070087
Submission received: 15 May 2017 / Revised: 14 July 2017 / Accepted: 17 July 2017 / Published: 19 July 2017
(This article belongs to the Special Issue Neuronal Migration and Cortical Development)

Abstract

:
During corticogenesis, neuronal migration is an essential step for formation of a functional brain, and abnormal migration is known to cause various neurological disorders. Neuronal migration is not just a simple movement of the cell body, but a consequence of various morphological changes and coordinated subcellular events. Recent advances in in vivo and ex vivo cell biological approaches, such as in utero gene transfer, slice culture and ex vivo chemical inhibitor techniques, have revealed details of the morphological and molecular aspects of neuronal migration. Migrating neurons have been found to have a unique structure, dilation or swelling, at the proximal region of the leading process; this structure is not found in other migrating cell types. The formation of this structure is followed by nuclear deformation and forward movement, and coordination of this three-step sequential morphological change (the dilation/swelling formation, nuclear elongation and nuclear movement) is essential for proper neuronal migration and the construction of a functional brain structure. In this review, we will introduce the morphological features of this unique structure in migrating neurons and summarize what is known about the molecules regulating the dilation/swelling formation and nuclear deformation and movement.

1. Introduction

One of the pronounced morphological features of the mammalian cerebral cortex is the six-layer structure composed of different neural cell types. Formation of this structure requires proper regulation of neuronal migration during developmental stages. Disruption of the cortical layer structure leads to several neurological disorders that are accompanied by mental retardation and/or epilepsy. These include lissencephaly, subcortical band heterotopia (also known as double cortex syndrome) and periventricular heterotopia [1,2].
During cortical development, the progenitors of cerebral cortical excitatory neurons proliferate mainly at the ventricular zone and produce immature neurons that radially migrate toward the brain surface while undergoing various morphological changes (Figure 1a) [3,4,5,6]. Newborn neurons first enter the early phase of migration, where they exhibit multipolar morphologies and undergo several neuronal maturation events, including the acquirement of neuronal polarity and axon outgrowth in the lower part of the intermediate zone or the subventricular zone. Subsequently, they transform into bipolar-shaped neurons with a leading process, the future apical dendrite. These bipolar-shaped neurons, called “locomoting neurons”, migrate over a relatively long distance from the upper part of the intermediate zone to nearly the top of the cortical plate. At the final phase of migration, these locomoting neurons switch into the terminal translocation mode and complete the migration. Thus, neuronal migration toward the final destination is associated with neuronal maturation.
On the other hand, cortical inhibitory interneurons are generated mainly at the medial ganglionic eminence (MGE) and migrate tangentially to the cortical wall through the subventricular zone or the marginal zone (Figure 1b) [7,8,9]. The majority of interneurons enter the marginal zone directly or indirectly from the subventricular zone and exhibit multi-directional migration in the marginal zone. Subsequently, they migrate radially into the cortical plate. On the other hand, other interneurons migrate from the subventricular zone to the cortical plate without entering the marginal zone (Figure 1b). In the former case, the final radial migration of the interneurons is opposite in direction to the radial migration of the excitatory neurons, although they both migrate along the radial glial fibers.
While many neuronal maturation events occur during the early phase of neuronal migration, the locomotion mode of neuronal migration comprises most of the migration path and is therefore a main contributor to cortical layer formation [10,11]. However, as conventional methods, including gene targeting and in utero electroporation, cannot eliminate various secondary effects of defects occurring at the early phase of migration, such as the acquirement of neuronal polarity, leading process formation and multipolar migration, it has been difficult to analyze the molecular mechanisms regulating this mode. Recently, several in vitro and ex vivo techniques, allowing direct analysis of molecules involved in the locomotion mode, have been established. These include explant culture [12], slice culture-based ex vivo chemical inhibitor technique [11,13], lattice culture [14,15], co-culture of primary cortical excitatory neurons and nestin-positive cells [16], co-culture of MGE explants on dissociated cortical neurons with elongated axons [17] and cortical imprint assay [18].
Among them, the ex vivo chemical inhibitor assay is an integrated method combining an in vivo electroporation, time-lapse imaging of cortical slice culture and chemical compound screening [11]. The locomoting neurons that are visualized with in vivo electroporated fluorescence proteins are observed with a time-lapse microscopy and the cortical slices are treated with a chemical compound, such as an inhibitor for a molecule of interest, during the time-lapse observation. Using this method, the migration speed and morphological changes of the same locomoting neurons before and after the inhibitor treatment can be analyzed.
Cyclin-dependent kinase 5 (Cdk5) is a key molecule for neuronal migration [19,20] and suppression of Cdk5 by conventional methods causes defects in the early phase of neuronal migration [21,22,23]. By using the ex vivo chemical inhibitor assay, Cdk5 was shown to also regulate the locomotion mode of neuronal migration [11]. In addition, while in vivo knockdown of Fyn, a major neuronal Src kinase, disturbs the early phase of migration [11,24], treatment of cortical slice tissues with an inhibitor for Src family kinases reduces the migration speed of the locomoting neurons [11].

2. Dilation/Swelling Formation

2.1. Morphological Features of Dilation and Swelling in Migrating Neurons

Locomoting neurons show neuron-specific unique migration features [12,13,17]. (1) Locomoting neurons extend a leading process and form a cytoplasmic “dilation” (also known as a “swelling”) at the proximal region of their leading process; (2) The nuclei in the locomoting neurons elongate to enter the cytoplasmic dilation.
The cytoplasmic dilation or swelling was first identified in 2005 as a migrating neuron-specific subcellular domain [12,17], and is not observed in other non-neuronal migrating cells as well as static neurons [12]. The dilation was transiently formed just adjacent to the soma in the migrating neurons derived from the explants of the postnatal subventricular zone [12] and in the excitatory neurons in the developmental cerebral cortex (Figure 2a) [13,25]. In 2005, the same year when the dilation was firstly reported, Metin et al. found a similar structure in inhibitory neurons and named it a “swelling” [17]. The swelling is formed at a slightly higher position relative to the soma in inhibitory neurons of the cerebral cortex (Figure 2b). It is unclear whether the dilation in the excitatory neurons and the swelling in the inhibitory neurons have distinct characters, other than the positions at which they are formed, but at least some molecules, including p27kip1, differentially regulate the dilation and swelling, as described below [13,26]. Although the terminology requires further consideration in the future, in this review, we will refer to these structures in cortical excitatory and inhibitory neurons as “dilation” and “swelling”, respectively.
Electron microscopy studies show that the dilation/swelling includes the centrosome, Golgi apparatus, clathrin-coated pits and microtubules [12,17,27]. Furthermore, actin filaments are concentrated at the dilation/swelling of the migrating neurons in the developing cerebellum and cerebral cortex [13,28,29]. While treatment with cytochalasin D or latrunculin B, inhibitors for actin polymerization, disrupts the tissue structure of cultured cortical slices and makes it difficult to gauge the requirement for actin polymerization in the dilation formation, treatment with nocodazole, which inhibits microtubule polymerization, disturbs the dilation formation of the locomoting neurons [13]. In addition, treatment with dynasore, an inhibitor for dynamin-mediated endocytosis, or transfection with shRNA for Rab5, which controls endocytosis and trafficking to the early endosomes, causes defects in the dilation formation (Figure 3) [13]. These observations suggest that the dilation/swelling formation requires coordinated cellular events, including cytoskeletal organization and membrane trafficking.

2.2. Molecular Mechanisms Underlying Dilation and Swelling Formation

A dynein complex, a microtubule minus end-directed motor, and microtubule-associated proteins, including MAP1B and Dcx, are reported to play essential roles in neuronal migration [25,30,31,32]. Knockdown of Dcx in rat brain disturbs neuronal migration, resulting in the formation of subcortical band heterotopia, similar to the human disease with a heterozygous mutation in the dcx gene [32], although the knockdown of Dcx may exhibit an off-targeting effect in mice [33]. Nevertheless, Dcx is required for neuronal migration, because Dcx-knockout neurons display delayed neuronal migration [34]. It has been reported that the average migration speeds of Dcx-knockout and Dcx-knockdown locomoting neurons are 69% and 66% of control neurons, respectively, and the Dcx-knockdown locomoting neurons exhibit reduced dilation formation [13,34]. In contrast, knockdown of the dynein heavy chain or Lis1, a dynein complex-associated protein, has little effect on the dilation formation, whereas it decreases the migration rate of cortical neurons [25]. This suggests that a Dcx-mediated cellular event(s) is required for the dilation formation, whereas dynein motor activity is dispensable (Figure 3). However, Dcx controls not only microtubule organization but also membrane trafficking and actin organization [35,36,37,38], and it is unclear which downstream event(s) mediates Dcx-dependent regulation of the dilation formation.
Cdk5 is known to directly phosphorylate Dcx [39]. Cdk5-mediated phosphorylation of Dcx reduces its microtubule-binding affinity [39]. Pharmacological or knockdown-mediated inhibition of Cdk5 suppresses the dilation formation (Figure 3) [13]. Consistent with the fact that suppression of Cdk5 increases the Dcx activity to control microtubule organization, overexpression of Dcx weakly suppresses the dilation formation of the locomoting neurons. In addition, knockdown of Dcx partially, but not fully, rescues the defects in the dilation formation in Cdk5-knockdown locomoting neurons [13]. Thus, both insufficient and excess Dcx lead to a similar phenotype, suggesting that proper regulation of Dcx activity by Cdk5 plays an important role in the dilation formation.
The fact that knockdown of Dcx cannot fully rescue the phenotypes of Cdk5-knockdown implies that (an)other downstream molecule(s) also play(s) a role in the dilation formation. To date, many downstream substrates have been identified [40]. Among them, p27kip1 is reported to be phosphorylated by Cdk5 at Ser10. This phosphorylation protects it from proteasome-dependent protein degradation, resulting in stabilization of the p27kip1 protein [22]. Knockdown of p27kip1 is shown to suppress dilation formation and the locomotion mode of the migration of cortical excitatory neurons (Figure 3) [13]. In contrast, suppression of p27kip1 in cortical inhibitory interneurons promotes the swelling formation [26], implicating the molecular differences in the dilation and swelling formation.
While p27kip1 is a CDK inhibitory protein and controls G1 length and cell cycle exit in the nucleus [41,42,43], recent studies have indicated that p27kip1 also functions in cytoplasm to regulate both actin and microtubule organization [22,26]. Although it is unclear which downstream event(s) of p27kip1 is important for the dilation formation, Cdk5 is thought to regulate both actin cytoskeleton and microtubules. This is because suppression of Cdk5 results in a decrease of actin accumulation at the dilation as well as perturbation of the Golgi positioning, which largely depends on microtubules and dynein motor activity, in the locomoting neurons [13]. Furthermore, knockdown or pharmacological inhibition of Cdk5 disturbs the microtubule organization in primary cortical neurons [13].
Actin organization is mediated by Rho family small GTPases, such as RhoA, Rac1 and Cdc42 [44,45]. While RhoA negatively controls neuronal migration [46] and is suppressed by Cdk5 and its downstream molecules, p27kip1 and Mst3 [22,47], Rac1 promotes neuronal migration; suppression of Rac1 by the expression of a dominant negative form or a knockdown vector or conditional gene targeting results in delayed or stalled neuronal migration [21,28,48,49]. While mDia proteins, downstream effectors of RhoA, are reported to regulate centrosomal positioning and nuclear translocation in tangentially migrating cortical inhibitory neurons, mDia deficiency does not impair the swelling formation [50]. In contrast, a scaffold protein, POSH, enhances the plasma membrane localization of an activated form of Rac1 and suppression of POSH or Rac1 reduces dilation formation (Figure 3) [28]. Furthermore, knockdown of POSH disturbs the actin accumulation at the dilation, suggesting that POSH and Rac1 promote the dilation formation through the regulation of actin organization [28]. It is known that Rac1 activates JNK, which regulates the leading process morphology and neuronal migration [21]. However, suppression of JNK does not affect the cross-sectional area of the dilation in the locomoting excitatory neurons, although JNK-suppressed neurons form an irregular shaped dilation, suggesting that regulation of dilation formation by Rac1 occurs mainly in a JNK-independent manner [13].
What is an environmental cue for the dilation/swelling formation? Although the migration of both excitatory and inhibitory neurons requires N-cadherin in vivo [16,51,52], cultured inhibitory interneurons migrating on a biomimetic N-cadherin substrate (but not cadherin-6, cadherin-11, E-cadherin and laminin substrates) exhibit fast migration in a non-saltatory fashion and have difficulty in forming the swelling, suggesting the importance of a balanced extracellular environment [52,53]. While radially migrating excitatory neurons in vivo form the dilation [13], an in vivo imaging study indicates that the swelling is rarely observed in cortical interneurons in the MZ, where the interneurons frequently change their migration direction unlike tangentially migrating interneurons from the MGE [54]. These observations suggest that an extracellular environment controls the dilation/swelling formation, which may be associated with directional and/or saltatory movement of the locomoting neurons.

3. Nuclear Deformation and Movement

3.1. Nuclear Deformation during the Locomotion

After the formation of the cytoplasmic dilation or swelling, the locomoting neurons deform their nuclei. Nuclear sphericity is transiently decreased and, accordingly, the ratio of the length to width of the nuclei is increased. The elongated nucleus moves forward and enters the dilation/swelling, and as a consequence, the dilation/swelling is replaced by the nucleus. Subsequently, the locomoting neurons form another dilation/swelling. This cycle of dilation/swelling formation, nuclear elongation and nuclear forward movement is repeated and results in the saltatory movement of the locomoting neurons [12,13,17].
Such a nuclear deformation is also observed in non-neuronal cells migrating through confined spaces. Cells migrating through dense extracellular matrix (ECM) transiently exhibit hourglass-like or cigar-shaped elongated morphologies [55,56]. Furthermore, real-time in vivo imaging revealed that cancer cells injected in the heart of nude mice display elongated nuclei during migration in the capillaries of the living mice [57]. The dilation/swelling formation, however, has never been observed in migrating non-neuronal cells [12]. Thus, the cytoplasmic dilation or swelling is a migrating neuron-specific unique structure, but the nuclear deformation is a broadly observed event in many cell types.

3.2. Molecules Regulating Nuclear Elongation

From the molecular aspect, the nuclear deformation is related to the cytoplasmic dilation formation. Suppression of Cdk5, Dcx, p27kip1 or Rab5 perturbs the nuclear elongation as well as dilation formation during the locomotion mode [13]. Involvement of actin rearrangement in the nuclear elongation of the locomoting neurons is unclear, whereas the nuclear deformation of non-neuronal cells requires several actin-binding proteins, including Arp2/3 complex and Fascin [58,59]. In contrast, treatment with nocodazole suppresses the nuclear deformation in neurons, suggesting that microtubule organization plays a role in the nuclear elongation of the locomoting neurons [13]. Previous observations reveal that cage-like microtubules surround the elongated nuclei in neurons [12,60,61], and Cdk5-mediated phosphorylation of focal adhesion kinase (FAK) at Ser732 is reported to control the perinuclear cage-like microtubule organization and nuclear elongation [62].
While JNK does not affect the cross-sectional area of the cytoplasmic dilation, knockdown of JNK suppresses the nuclear elongation (Figure 3), suggesting that Cdk5 and JNK, both of which are known to control microtubule dynamics [21,30], have different roles in the locomotion mode [13]. Although it is unclear whether JNK activation can occur downstream of Cdk5, suppression of Rac1 or Rab5, which disturbs the dilation formation, decreases the activity of JNK in cortical neurons [16,21], implying that JNK might be a factor connecting dilation formation and nuclear elongation.
In line with this, an interesting question is whether the dilation/swelling formation and nuclear deformation are independently regulated or whether the dilation/swelling formation induces the nuclear deformation. As described above, suppression of many of the molecules involved in the dilation formation leads to defects in the nuclear elongation. However, time-lapse imaging revealed that treatment with an inhibitor for CDKs, including Cdk5, quickly suppresses the dilation formation but gradually increases nuclear sphericity as the nuclear movement is inhibited [13]. Thus, a primary target of Cdk5 may be dilation formation, and defects in nuclear deformation in the Cdk5-suppressing locomoting neurons may be secondary to abnormalities in the dilation formation or nuclear movement. This may explain why most of the molecules analyzed in the previous studies are involved in both the dilation formation and nuclear deformation.
On the contrary, the fact that migrating non-neuronal cells exhibit nuclear deformation without forming the dilation or swelling may support the former hypothesis; dilation/swelling formation and nuclear elongation are independent. In fact, Cdk5 may regulate dilation formation and nuclear deformation through different downstream pathways; the Dcx- and p27kip1-mediated [13] and the FAK-mediated [62], respectively. It may be important to identify events upstream of JNK activation, because it may provide a clue clarifying whether dilation formation induces the JNK-mediated nuclear deformation or whether other molecular pathways activate it in a dilation formation-independent manner.

3.3. The Forward Movement of the Nucleus

Considering that the elongated (migrating) nuclei are surrounded by the cage-like microtubules, perinuclear microtubules are thought to regulate the nuclear forward movement. In fact, suppression of dynein or Lis1 results in abnormally increased distance between the centrosome and nuclei, but has no effect on the dilation formation, suggesting that retrograde transport on microtubules plays an important role in nuclear movement [25,39]. PDK1 and its downstream molecule, Akt, have been shown to promote the somal migration speed of the locomoting neurons through the regulation of coordinated movement of the nucleus and centrosome [63]. Although PDK1 may not directly regulate the nuclear movement, PDK1 is required for the binding of Lis1 and p150Glued, a subunit of the dynein–dynactin complex, to microtubules and promotes the formation of perinuclear cage-like (mesh-like) microtubules and the centrosomal movement [63].
Given that dynein-mediated microtubule retrograde motor activity is involved in the nuclear movement, it requires a factor that would link the nucleus with the perinuclear microtubules. SUN-domain proteins, Sun1 and Sun2, and KASH-domain proteins, Nesprin-1 and Nesprin-2, are components of the linker of the nucleoskeleton and cytoskeleton (LINC). Sun1/2 are transmembrane proteins that are localized at the inner nuclear membrane of the nuclear envelope and directly bind to A- and B-type nuclear lamins, whereas Nesprin1/2 are transmembrane proteins spanning the outer nuclear membrane and interact with the dynein–dynactin complex [64,65,66]. Sun1/2- or Nesprin1/2-deficient mice show defects in both nuclear movement and centrosome-nucleus coupling in cortical neurons [64]. Lamin B2-deficient mice also exhibit neuronal migration defects in the developing cerebral cortex [67]. Thus, the SUN and KASH proteins function to link the nucleus to the microtubules and are required for proper nuclear movement in migrating neurons (Figure 3).
In addition to microtubules, actomyosin-mediated contractility is known to play an important role in the nuclear forward movement (Figure 3). A study using a traction force microscopy shows that migrating cerebellar granule neurons have three contraction centers at the distal and proximal regions of the leading process and the posterior end of the neurons [68]. Actomyosin-mediated contractility at the posterior end of the migrating neurons, where activated myosin II is observed, pushes up the nuclei in the migrating neurons [12,69]. Myosin II is also observed at the proximal region of the leading process and controls the coordinated movement of the centrosome and soma in migrating cerebellar granule neurons [29]. In addition, local perfusion with latrunculin A, an F-actin depolymerizing agent, at the leading process, but not the soma, suppresses the nuclear movement in cultured cerebellar granule neurons [70]. On the other hand, in the locomoting neurons in the developing cerebral cortex, treatment with blebbistatin, an inhibitor for myosin activity, or knockdown of myosin IIB blocks the nuclear forward movement, but has no effect on the centrosomal movement [25]. At any rate, actin polymerization and actomyosin-mediated contractility are important for the nuclear movement of the migrating neurons, whereas the involvement of actomyosin contractility in the centrosomal movement may depend on neuronal subtypes.
The accumulation of actomyosin is controlled by an Elongator complex that is known to regulate the acetylation of tubulin in neurons and proper tRNA modifications in neural progenitors [71,72]. Conditional deletion of Elp3, an enzymatic core subunit of the Elongator complex, in cortical inhibitory interneurons increases the depolymerization of actin filaments and perturbs the accumulation of actomyosin at the nuclear rear or trailing process, resulting in reduction of the nuclear migration velocity [73]. Interestingly, deficiency of Elp3 suppresses the swelling formation in cortical inhibitory interneurons, suggesting its multiple roles in coordinated neuronal migration.

4. Conclusions

Morphological changes of migrating neurons are essential for proper brain formation. Recent advances in in vivo cell biological approaches have helped to uncover the unique features of neuronal migration; the dilation/swelling formation and nuclear deformation. However, the differences in the mechanisms regulating the dilation and swelling formation and the correlation between the dilation/swelling formation and nuclear deformation remain to be further clarified. Future studies to identify mechanisms regulating the dilation/swelling may shed more insight into the neuronal migration during cortical development.

Acknowledgments

The authors thank Ruth T. Yu for critical reading of the manuscript and Daisuke H. Tanaka for comments about cortical interneuron migration. The authors’ research group is funded by JSPS KAKENHI Grant Numbers JP26290015 (to T.K.) and JP25870900 (to Y.V.N.) and Grant-in Scientific Research on Innovation Areas “Dynamic regulation of Brain Function by Scrap & Build System” (JP17H05757) (to T.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), the Takeda Science Foundation (to T.K.) and the Uehara Memorial Foundation (to T.K.).

Author Contributions

Y.V.N. and T.K. wrote the manuscript. Y.-i.N. gave critical comments for the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gleeson, J.G.; Walsh, C.A. Neuronal migration disorders: From genetic diseases to developmental mechanisms. Trends Neurosci. 2000, 23, 352–359. [Google Scholar] [CrossRef]
  2. Kawauchi, T.; Hoshino, M. Molecular pathways regulating cytoskeletal organization and morphological changes in migrating neurons. Dev. Neurosci. 2008, 30, 36–46. [Google Scholar] [CrossRef] [PubMed]
  3. Ayala, R.; Shu, T.; Tsai, L.H. Trekking across the brain: The journey of neuronal migration. Cell 2007, 128, 29–43. [Google Scholar] [CrossRef] [PubMed]
  4. Heng, J.I.; Chariot, A.; Nguyen, L. Molecular layers underlying cytoskeletal remodelling during cortical development. Trends Neurosci. 2010, 33, 38–47. [Google Scholar] [CrossRef] [PubMed]
  5. Cooper, J.A. Molecules and mechanisms that regulate multipolar migration in the intermediate zone. Front Cell. Neurosci. 2014, 8, 386. [Google Scholar] [CrossRef] [PubMed]
  6. Kawauchi, T. Cellullar insights into cerebral cortical development: Focusing on the locomotion mode of neuronal migration. Front Cell. Neurosci. 2015, 9, 394. [Google Scholar] [CrossRef] [PubMed]
  7. Guo, J.; Anton, E.S. Decision making during interneuron migration in the developing cerebral cortex. Trends Cell Biol. 2014, 24, 342–351. [Google Scholar] [CrossRef] [PubMed]
  8. Marin, O.; Valiente, M.; Ge, X.; Tsai, L.H. Guiding neuronal cell migrations. Cold Spring Harb. Perspect. Biol. 2010, 2, a001834. [Google Scholar] [CrossRef] [PubMed]
  9. Metin, C.; Baudoin, J.P.; Rakic, S.; Parnavelas, J.G. Cell and molecular mechanisms involved in the migration of cortical interneurons. Eur. J. Neurosci. 2006, 23, 894–900. [Google Scholar] [CrossRef] [PubMed]
  10. Rakic, P. A century of progress in corticoneurogenesis: From silver impregnation to genetic engineering. Cereb. Cortex 2006, 16, i3–i17. [Google Scholar] [CrossRef] [PubMed]
  11. Nishimura, Y.V.; Sekine, K.; Chihama, K.; Nakajima, K.; Hoshino, M.; Nabeshima, Y.; Kawauchi, T. Dissecting the factors involved in the locomotion mode of neuronal migration in the developing cerebral cortex. J. Biol. Chem. 2010, 285, 5878–5887. [Google Scholar] [CrossRef] [PubMed]
  12. Schaar, B.T.; McConnell, S.K. Cytoskeletal coordination during neuronal migration. Proc. Natl. Acad. Sci. USA 2005, 102, 13652–13657. [Google Scholar] [CrossRef] [PubMed]
  13. Nishimura, Y.V.; Shikanai, M.; Hoshino, M.; Ohshima, T.; Nabeshima, Y.; Mizutani, K.; Nagata, K.; Nakajima, K.; Kawauchi, T. Cdk5 and its substrates, Dcx and p27kip1, regulate cytoplasmic dilation formation and nuclear elongation in migrating neurons. Development 2014, 141, 3540–3550. [Google Scholar] [CrossRef] [PubMed]
  14. Nichols, A.J.; Carney, L.H.; Olson, E.C. Comparison of slow and fast neocortical neuron migration using a new in vitro model. BMC Neurosci. 2008, 9, 50. [Google Scholar] [CrossRef] [PubMed]
  15. Asada, N.; Sanada, K. LKB1-mediated spatial control of GSK3beta and adenomatous polyposis coli contributes to centrosomal forward movement and neuronal migration in the developing neocortex. J. Neurosci. 2010, 30, 8852–8865. [Google Scholar] [CrossRef] [PubMed]
  16. Kawauchi, T.; Sekine, K.; Shikanai, M.; Chihama, K.; Tomita, K.; Kubo, K.; Nakajima, K.; Nabeshima, Y.; Hoshino, M. Rab GTPases-dependent endocytic pathways regulate neuronal migration and maturation through N-cadherin trafficking. Neuron 2010, 67, 588–602. [Google Scholar] [CrossRef] [PubMed]
  17. Bellion, A.; Baudoin, J.P.; Alvarez, C.; Bornens, M.; Metin, C. Nucleokinesis in tangentially migrating neurons comprises two alternating phases: Forward migration of the Golgi/centrosome associated with centrosome splitting and myosin contraction at the rear. J. Neurosci. 2005, 25, 5691–5699. [Google Scholar] [CrossRef] [PubMed]
  18. Anton, E.S.; Marchionni, M.A.; Lee, K.F.; Rakic, P. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 1997, 124, 3501–3510. [Google Scholar] [PubMed]
  19. Chae, T.; Kwon, Y.T.; Bronson, R.; Dikkes, P.; Li, E.; Tsai, L.H. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18, 29–42. [Google Scholar] [CrossRef]
  20. Gilmore, E.C.; Ohshima, T.; Goffinet, A.M.; Kulkarni, A.B.; Herrup, K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J. Neurosci. 1998, 18, 6370–6377. [Google Scholar] [PubMed]
  21. Kawauchi, T.; Chihama, K.; Nabeshima, Y.; Hoshino, M. The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. EMBO J. 2003, 22, 4190–4201. [Google Scholar] [CrossRef] [PubMed]
  22. Kawauchi, T.; Chihama, K.; Nabeshima, Y.; Hoshino, M. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat. Cell Biol. 2006, 8, 17–26. [Google Scholar] [CrossRef] [PubMed]
  23. Ohshima, T.; Hirasawa, M.; Tabata, H.; Mutoh, T.; Adachi, T.; Suzuki, H.; Saruta, K.; Iwasato, T.; Itohara, S.; Hashimoto, M.; et al. Cdk5 is required for multipolar-to-bipolar transition during radial neuronal migration and proper dendrite development of pyramidal neurons in the cerebral cortex. Development 2007, 134, 2273–2282. [Google Scholar] [CrossRef] [PubMed]
  24. Huang, Y.; Li, G.; An, L.; Fan, Y.; Cheng, X.; Li, X.; Yin, Y.; Cong, R.; Chen, S.; Zhao, S. Fyn regulates multipolar-bipolar transition and neurite morphogenesis of migrating neurons in the developing neocortex. Neuroscience 2017, 352, 39–51. [Google Scholar] [CrossRef] [PubMed]
  25. Tsai, J.W.; Bremner, K.H.; Vallee, R.B. Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue. Nat. Neurosci. 2007, 10, 970–979. [Google Scholar] [CrossRef] [PubMed]
  26. Godin, J.D.; Thomas, N.; Laguesse, S.; Malinouskaya, L.; Close, P.; Malaise, O.; Purnelle, A.; Raineteau, O.; Campbell, K.; Fero, M.; et al. p27Kip1 is a microtubule-associated protein that promotes microtubule polymerization during neuron migration. Dev. Cell 2012, 23, 729–744. [Google Scholar] [CrossRef] [PubMed]
  27. Shieh, J.C.; Schaar, B.T.; Srinivasan, K.; Brodsky, F.M.; McConnell, S.K. Endocytosis regulates cell soma translocation and the distribution of adhesion proteins in migrating neurons. PLoS ONE 2011, 6, e17802. [Google Scholar] [CrossRef] [PubMed]
  28. Yang, T.; Sun, Y.; Zhang, F.; Zhu, Y.; Shi, L.; Li, H.; Xu, Z. POSH localizes activated Rac1 to control the formation of cytoplasmic dilation of the leading process and neuronal migration. Cell Rep. 2012, 2, 640–651. [Google Scholar] [CrossRef] [PubMed]
  29. Solecki, D.J.; Trivedi, N.; Govek, E.E.; Kerekes, R.A.; Gleason, S.S.; Hatten, M.E. Myosin II motors and F-actin dynamics drive the coordinated movement of the centrosome and soma during CNS glial-guided neuronal migration. Neuron 2009, 63, 63–80. [Google Scholar] [CrossRef] [PubMed]
  30. Kawauchi, T.; Chihama, K.; Nishimura, Y.V.; Nabeshima, Y.; Hoshino, M. MAP1B phosphorylation is differentially regulated by Cdk5/p35, Cdk5/p25, and JNK. Biochem. Biophys. Res. Commun. 2005, 331, 50–55. [Google Scholar] [CrossRef] [PubMed]
  31. Takei, Y.; Teng, J.; Harada, A.; Hirokawa, N. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J. Cell Biol. 2000, 150, 989–1000. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Bai, J.; Ramos, R.L.; Ackman, J.B.; Thomas, A.M.; Lee, R.V.; LoTurco, J.J. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat. Neurosci. 2003, 6, 1277–1283. [Google Scholar] [CrossRef] [PubMed]
  33. Baek, S.T.; Kerjan, G.; Bielas, S.L.; Lee, J.E.; Fenstermaker, A.G.; Novarino, G.; Gleeson, J.G. Off-target effect of doublecortin family shRNA on neuronal migration associated with endogenous microRNA dysregulation. Neuron 2014, 82, 1255–1262. [Google Scholar] [CrossRef] [PubMed]
  34. Pramparo, T.; Youn, Y.H.; Yingling, J.; Hirotsune, S.; Wynshaw-Boris, A. Novel embryonic neuronal migration and proliferation defects in Dcx mutant mice are exacerbated by Lis1 reduction. J. Neurosci. 2010, 30, 3002–3012. [Google Scholar] [CrossRef] [PubMed]
  35. Tsukada, M.; Prokscha, A.; Ungewickell, E.; Eichele, G. Doublecortin association with actin filaments is regulated by neurabin II. J. Biol. Chem. 2005, 280, 11361–11368. [Google Scholar] [CrossRef] [PubMed]
  36. Fu, X.; Brown, K.J.; Yap, C.C.; Winckler, B.; Jaiswal, J.K.; Liu, J.S. Doublecortin (Dcx) family proteins regulate filamentous actin structure in developing neurons. J. Neurosci. 2013, 33, 709–721. [Google Scholar] [CrossRef] [PubMed]
  37. Yap, C.C.; Vakulenko, M.; Kruczek, K.; Motamedi, B.; Digilio, L.; Liu, J.S.; Winckler, B. Doublecortin (DCX) mediates endocytosis of neurofascin independently of microtubule binding. J. Neurosci. 2012, 32, 7439–7453. [Google Scholar] [CrossRef] [PubMed]
  38. Friocourt, G.; Chafey, P.; Billuart, P.; Koulakoff, A.; Vinet, M.C.; Schaar, B.T.; McConnell, S.K.; Francis, F.; Chelly, J. Doublecortin interacts with mu subunits of clathrin adaptor complexes in the developing nervous system. Mol. Cell. Neurosci. 2001, 18, 307–319. [Google Scholar] [CrossRef] [PubMed]
  39. Tanaka, T.; Serneo, F.F.; Tseng, H.C.; Kulkarni, A.B.; Tsai, L.H.; Gleeson, J.G. Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron 2004, 41, 215–227. [Google Scholar] [CrossRef]
  40. Kawauchi, T. Cdk5 regulates multiple cellular events in neural development, function and disease. Dev. Growth Differ. 2014, 56, 335–348. [Google Scholar] [CrossRef] [PubMed]
  41. Sherr, C.J.; Roberts, J.M. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13, 1501–1512. [Google Scholar] [CrossRef] [PubMed]
  42. Mitsuhashi, T.; Aoki, Y.; Eksioglu, Y.Z.; Takahashi, T.; Bhide, P.G.; Reeves, S.A.; Caviness, V.S., Jr. Overexpression of p27Kip1 lengthens the G1 phase in a mouse model that targets inducible gene expression to central nervous system progenitor cells. Proc. Natl. Acad. Sci. USA 2001, 98, 6435–6440. [Google Scholar] [CrossRef] [PubMed]
  43. Tarui, T.; Takahashi, T.; Nowakowski, R.S.; Hayes, N.L.; Bhide, P.G.; Caviness, V.S. Overexpression of p27Kip1, probability of cell cycle exit, and laminar destination of neocortical neurons. Cereb. Cortex 2005, 15, 1343–1355. [Google Scholar] [CrossRef] [PubMed]
  44. Nobes, C.D.; Hall, A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81, 53–62. [Google Scholar] [CrossRef]
  45. Govek, E.E.; Hatten, M.E.; Van Aelst, L. The role of Rho GTPase proteins in CNS neuronal migration. Dev. Neurobiol. 2011, 71, 528–553. [Google Scholar] [CrossRef] [PubMed]
  46. Ge, W.; He, F.; Kim, K.J.; Blanchi, B.; Coskun, V.; Nguyen, L.; Wu, X.; Zhao, J.; Heng, J.I.; Martinowich, K.; et al. Coupling of cell migration with neurogenesis by proneural bHLH factors. Proc. Natl. Acad. Sci. USA 2006, 103, 1319–1324. [Google Scholar] [CrossRef] [PubMed]
  47. Tang, J.; Ip, J.P.; Ye, T.; Ng, Y.P.; Yung, W.H.; Wu, Z.; Fang, W.; Fu, A.K.; Ip, N.Y. Cdk5-dependent Mst3 phosphorylation and activity regulate neuronal migration through RhoA inhibition. J. Neurosci. 2014, 34, 7425–7436. [Google Scholar] [CrossRef] [PubMed]
  48. Chen, L.; Liao, G.; Waclaw, R.R.; Burns, K.A.; Linquist, D.; Campbell, K.; Zheng, Y.; Kuan, C.Y. Rac1 controls the formation of midline commissures and the competency of tangential migration in ventral telencephalic neurons. J. Neurosci. 2007, 27, 3884–3893. [Google Scholar] [CrossRef] [PubMed]
  49. Tahirovic, S.; Hellal, F.; Neukirchen, D.; Hindges, R.; Garvalov, B.K.; Flynn, K.C.; Stradal, T.E.; Chrostek-Grashoff, A.; Brakebusch, C.; Bradke, F. Rac1 regulates neuronal polarization through the WAVE complex. J. Neurosci. 2010, 30, 6930–6943. [Google Scholar] [CrossRef] [PubMed]
  50. Shinohara, R.; Thumkeo, D.; Kamijo, H.; Kaneko, N.; Sawamoto, K.; Watanabe, K.; Takebayashi, H.; Kiyonari, H.; Ishizaki, T.; Furuyashiki, T.; et al. A role for mDia, a Rho-regulated actin nucleator, in tangential migration of interneuron precursors. Nat. Neurosci. 2012, 15, 373–380, S371–S372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Shikanai, M.; Nakajima, K.; Kawauchi, T. N-cadherin regulates radial glial fiber-dependent migration of cortical locomoting neurons. Commun. Integr. Biol. 2011, 4, 326–330. [Google Scholar] [CrossRef] [PubMed]
  52. Luccardini, C.; Hennekinne, L.; Viou, L.; Yanagida, M.; Murakami, F.; Kessaris, N.; Ma, X.; Adelstein, R.S.; Mege, R.M.; Metin, C. N-cadherin sustains motility and polarity of future cortical interneurons during tangential migration. J. Neurosci. 2013, 33, 18149–18160. [Google Scholar] [CrossRef] [PubMed]
  53. Luccardini, C.; Leclech, C.; Viou, L.; Rio, J.P.; Metin, C. Cortical interneurons migrating on a pure substrate of N-cadherin exhibit fast synchronous centrosomal and nuclear movements and reduced ciliogenesis. Front. Cell. Neurosci. 2015, 9, 286. [Google Scholar] [CrossRef] [PubMed]
  54. Yanagida, M.; Miyoshi, R.; Toyokuni, R.; Zhu, Y.; Murakami, F. Dynamics of the leading process, nucleus, and Golgi apparatus of migrating cortical interneurons in living mouse embryos. Proc. Natl. Acad. Sci. USA 2012, 109, 16737–16742. [Google Scholar] [CrossRef] [PubMed]
  55. Friedl, P.; Wolf, K.; Lammerding, J. Nuclear mechanics during cell migration. Curr. Opin. Cell Biol. 2011, 23, 55–64. [Google Scholar] [CrossRef] [PubMed]
  56. Wolf, K.; Te Lindert, M.; Krause, M.; Alexander, S.; Te Riet, J.; Willis, A.L.; Hoffman, R.M.; Figdor, C.G.; Weiss, S.J.; Friedl, P. Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J. Cell Biol. 2013, 201, 1069–1084. [Google Scholar] [CrossRef] [PubMed]
  57. Yamauchi, K.; Yang, M.; Jiang, P.; Yamamoto, N.; Xu, M.; Amoh, Y.; Tsuji, K.; Bouvet, M.; Tsuchiya, H.; Tomita, K.; et al. Real-time in vivo dual-color imaging of intracapillary cancer cell and nucleus deformation and migration. Cancer Res. 2005, 65, 4246–4252. [Google Scholar] [CrossRef] [PubMed]
  58. Thiam, H.R.; Vargas, P.; Carpi, N.; Crespo, C.L.; Raab, M.; Terriac, E.; King, M.C.; Jacobelli, J.; Alberts, A.S.; Stradal, T.; et al. Perinuclear Arp2/3-driven actin polymerization enables nuclear deformation to facilitate cell migration through complex environments. Nat. Commun. 2016, 7, 10997. [Google Scholar] [CrossRef] [PubMed]
  59. Jayo, A.; Malboubi, M.; Antoku, S.; Chang, W.; Ortiz-Zapater, E.; Groen, C.; Pfisterer, K.; Tootle, T.; Charras, G.; Gundersen, G.G.; et al. Fascin regulates nuclear movement and deformation in migrating cells. Dev. Cell 2016, 38, 371–383. [Google Scholar] [CrossRef] [PubMed]
  60. Rivas, R.J.; Hatten, M.E. Motility and cytoskeletal organization of migrating cerebellar granule neurons. J. Neurosci. 1995, 15, 981–989. [Google Scholar] [PubMed]
  61. Umeshima, H.; Hirano, T.; Kengaku, M. Microtubule-based nuclear movement occurs independently of centrosome positioning in migrating neurons. Proc. Natl. Acad. Sci. USA 2007, 104, 16182–16187. [Google Scholar] [CrossRef] [PubMed]
  62. Xie, Z.; Sanada, K.; Samuels, B.A.; Shih, H.; Tsai, L.H. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 2003, 114, 469–482. [Google Scholar] [CrossRef]
  63. Itoh, Y.; Higuchi, M.; Oishi, K.; Kishi, Y.; Okazaki, T.; Sakai, H.; Miyata, T.; Nakajima, K.; Gotoh, Y. PDK1-Akt pathway regulates radial neuronal migration and microtubules in the developing mouse neocortex. Proc. Natl. Acad. Sci. USA 2016, 113, E2955–E2964. [Google Scholar] [CrossRef] [PubMed]
  64. Zhang, X.; Lei, K.; Yuan, X.; Wu, X.; Zhuang, Y.; Xu, T.; Xu, R.; Han, M. SUN1/2 and Syne/Nesprin-1/2 complexes connect centrosome to the nucleus during neurogenesis and neuronal migration in mice. Neuron 2009, 64, 173–187. [Google Scholar] [CrossRef] [PubMed]
  65. Burke, B.; Roux, K.J. Nuclei take a position: Managing nuclear location. Dev. Cell 2009, 17, 587–597. [Google Scholar] [CrossRef] [PubMed]
  66. Razafsky, D.; Hodzic, D. Bringing KASH under the SUN: The many faces of nucleo-cytoskeletal connections. J. Cell Biol. 2009, 186, 461–472. [Google Scholar] [CrossRef] [PubMed]
  67. Coffinier, C.; Chang, S.Y.; Nobumori, C.; Tu, Y.; Farber, E.A.; Toth, J.I.; Fong, L.G.; Young, S.G. Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. Proc. Natl. Acad. Sci. USA 2010, 107, 5076–5081. [Google Scholar] [CrossRef] [PubMed]
  68. Jiang, J.; Zhang, Z.H.; Yuan, X.B.; Poo, M.M. Spatiotemporal dynamics of traction forces show three contraction centers in migratory neurons. J. Cell Biol. 2015, 209, 759–774. [Google Scholar] [CrossRef] [PubMed]
  69. Martini, F.J.; Valdeolmillos, M. Actomyosin contraction at the cell rear drives nuclear translocation in migrating cortical interneurons. J. Neurosci. 2010, 30, 8660–8670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. He, M.; Zhang, Z.H.; Guan, C.B.; Xia, D.; Yuan, X.B. Leading tip drives soma translocation via forward F-actin flow during neuronal migration. J. Neurosci. 2010, 30, 10885–10898. [Google Scholar] [CrossRef] [PubMed]
  71. Creppe, C.; Malinouskaya, L.; Volvert, M.L.; Gillard, M.; Close, P.; Malaise, O.; Laguesse, S.; Cornez, I.; Rahmouni, S.; Ormenese, S.; et al. Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell 2009, 136, 551–564. [Google Scholar] [CrossRef] [PubMed]
  72. Laguesse, S.; Creppe, C.; Nedialkova, D.D.; Prevot, P.P.; Borgs, L.; Huysseune, S.; Franco, B.; Duysens, G.; Krusy, N.; Lee, G.; et al. A dynamic unfolded protein response contributes to the control of cortical neurogenesis. Dev. Cell 2015, 35, 553–567. [Google Scholar] [CrossRef] [PubMed]
  73. Tielens, S.; Huysseune, S.; Godin, J.D.; Chariot, A.; Malgrange, B.; Nguyen, L. Elongator controls cortical interneuron migration by regulating actomyosin dynamics. Cell Res. 2016, 26, 1131–1148. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Migration mode and morphological changes of migrating neurons. (a) Cortical excitatory projection neurons (light green cells) are mainly generated in the ventricular zone (VZ) and transform into multipolar cells in the lower part of intermediate zone (IZ) or the subventricular zone (SVZ). Subsequently, these neurons transform into locomoting cells with a leading process in the upper part of the IZ. Locomoting cells migrate along the radial fibers of their progenitors (dark green cells) in the cortical plate (CP), and at the final term of locomotion, they contact the pial surface with the tip of the leading processes and translocate their nuclei (terminal translocation mode); (b) Cortical inhibitory interneurons are mainly born in the medial ganglionic eminence (MGE) and migrate tangentially through the cortex. There are three migration routes of cortical interneurons: (1) neurons migrate from the SVZ to the marginal zone (MZ) and after exhibiting non-directional movement in the MZ, they migrate into the CP, (2) neurons migrate from the SVZ to the CP, and (3) neurons directly migrate from the MGE to the MZ and subsequently migrate into the CP. Although the third route might be rare in vivo, it is frequently observed in the slice culture. LGE: lateral ganglionic eminence.
Figure 1. Migration mode and morphological changes of migrating neurons. (a) Cortical excitatory projection neurons (light green cells) are mainly generated in the ventricular zone (VZ) and transform into multipolar cells in the lower part of intermediate zone (IZ) or the subventricular zone (SVZ). Subsequently, these neurons transform into locomoting cells with a leading process in the upper part of the IZ. Locomoting cells migrate along the radial fibers of their progenitors (dark green cells) in the cortical plate (CP), and at the final term of locomotion, they contact the pial surface with the tip of the leading processes and translocate their nuclei (terminal translocation mode); (b) Cortical inhibitory interneurons are mainly born in the medial ganglionic eminence (MGE) and migrate tangentially through the cortex. There are three migration routes of cortical interneurons: (1) neurons migrate from the SVZ to the marginal zone (MZ) and after exhibiting non-directional movement in the MZ, they migrate into the CP, (2) neurons migrate from the SVZ to the CP, and (3) neurons directly migrate from the MGE to the MZ and subsequently migrate into the CP. Although the third route might be rare in vivo, it is frequently observed in the slice culture. LGE: lateral ganglionic eminence.
Brainsci 07 00087 g001
Figure 2. Morphological changes of leading processes of migrating neurons. (a) Cortical projection neurons extend a leading process and form a cytoplasmic “dilation” at the proximal region of a leading process, and the nucleus in the locomoting neurons becomes elongated to enter the cytoplasmic dilation; (b) Cortical interneurons extend a leading process, a cytoplasmic swelling is formed at the relatively distal region of the process and subsequently the nucleus enters the cytoplasmic swelling.
Figure 2. Morphological changes of leading processes of migrating neurons. (a) Cortical projection neurons extend a leading process and form a cytoplasmic “dilation” at the proximal region of a leading process, and the nucleus in the locomoting neurons becomes elongated to enter the cytoplasmic dilation; (b) Cortical interneurons extend a leading process, a cytoplasmic swelling is formed at the relatively distal region of the process and subsequently the nucleus enters the cytoplasmic swelling.
Brainsci 07 00087 g002
Figure 3. Molecules regulating the dilation formation and nuclear deformation in locomoting neurons. POSH-mediated regulation of Rac1 localization and its downstream actin reorganization, Rab5-mediated endocytic pathways and Cdk5-Dcx/p27kip1 pathways, regulate dilation formation. JNK, as well as POSH-Rac1, Rab5, Cdk5-Dcx/p27kip1 are required for nuclear elongation. Dynein/Lis1, Sun1/2, Nesprin1/2 and Myosin II control nuclear movement. Yellow and orange circles indicate the nucleus and centrosome, respectively. Blue and red lines indicate microtubules and F-actin, respectively. See the text for more details.
Figure 3. Molecules regulating the dilation formation and nuclear deformation in locomoting neurons. POSH-mediated regulation of Rac1 localization and its downstream actin reorganization, Rab5-mediated endocytic pathways and Cdk5-Dcx/p27kip1 pathways, regulate dilation formation. JNK, as well as POSH-Rac1, Rab5, Cdk5-Dcx/p27kip1 are required for nuclear elongation. Dynein/Lis1, Sun1/2, Nesprin1/2 and Myosin II control nuclear movement. Yellow and orange circles indicate the nucleus and centrosome, respectively. Blue and red lines indicate microtubules and F-actin, respectively. See the text for more details.
Brainsci 07 00087 g003

Share and Cite

MDPI and ACS Style

Nishimura, Y.V.; Nabeshima, Y.-i.; Kawauchi, T. Morphological and Molecular Basis of Cytoplasmic Dilation and Swelling in Cortical Migrating Neurons. Brain Sci. 2017, 7, 87. https://doi.org/10.3390/brainsci7070087

AMA Style

Nishimura YV, Nabeshima Y-i, Kawauchi T. Morphological and Molecular Basis of Cytoplasmic Dilation and Swelling in Cortical Migrating Neurons. Brain Sciences. 2017; 7(7):87. https://doi.org/10.3390/brainsci7070087

Chicago/Turabian Style

Nishimura, Yoshiaki V., Yo-ichi Nabeshima, and Takeshi Kawauchi. 2017. "Morphological and Molecular Basis of Cytoplasmic Dilation and Swelling in Cortical Migrating Neurons" Brain Sciences 7, no. 7: 87. https://doi.org/10.3390/brainsci7070087

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop